{"filing":{"accession_number":"0001628280-26-048830","cik":"0001620737","ticker":"OGI","company_name":"ORGANIGRAM GLOBAL INC.","form":"6-K","filing_date":"2026-07-20","report_date":null,"primary_document":"form6-kxjuly202026.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1620737/000162828026048830/form6-kxjuly202026.htm"},"events":[{"id":18856,"run_id":16960,"accession_number":"0001628280-26-048830","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"This press release provides a business update on Organigram's operational performance following its April 2026 acquisition of Sanity Group GmbH, including Sanity's market share in Germany (~10%), Canadian market share metrics across key categories (flower, vapes, pre-rolls), and sequential improvements in Q2 FY2026. While the disclosure includes forward-looking guidance on Q3 reporting and an investor session, the core substance is an operational update on post-acquisition integration and market positioning rather than a discrete event (M\u0026A completion already occurred in April) or periodic financial results. The material market share data and performance metrics would affect a reasonable investor's assessment of the company's competitive position and acquisition success.","company_name":"ORGANIGRAM GLOBAL INC.","ticker":"OGI","filing_date":"2026-07-20","form":"6-K","submitted_at":null,"items":[{"id":17795,"accession_number":"0001628280-26-048830","item_number":"EX-99.1","item_title":"corporateupdatepressreleas.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This press release provides a business update on Organigram's operational performance following its April 2026 acquisition of Sanity Group GmbH, including Sanity's market share in Germany (~10%), Canadian market share metrics across key categories (flower, vapes, pre-rolls), and sequential improvements in Q2 FY2026. While the disclosure includes forward-looking guidance on Q3 reporting and an investor session, the core substance is an operational update on post-acquisition integration and market positioning rather than a discrete event (M\u0026A completion already occurred in April) or periodic financial results. The material market share data and performance metrics would affect a reasonable investor's assessment of the company's competitive position and acquisition success.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-20T20:53:50.831961+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17795,"accession_number":"0001628280-26-048830","item_number":"EX-99.1","item_title":"corporateupdatepressreleas.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This press release provides a business update on Organigram's operational performance following its April 2026 acquisition of Sanity Group GmbH, including Sanity's market share in Germany (~10%), Canadian market share metrics across key categories (flower, vapes, pre-rolls), and sequential improvements in Q2 FY2026. While the disclosure includes forward-looking guidance on Q3 reporting and an investor session, the core substance is an operational update on post-acquisition integration and market positioning rather than a discrete event (M\u0026A completion already occurred in April) or periodic financial results. The material market share data and performance metrics would affect a reasonable investor's assessment of the company's competitive position and acquisition success.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-20T20:53:50.831961+00:00","company_name":"ORGANIGRAM GLOBAL INC.","ticker":"OGI","filing_date":"2026-07-20"}]}